Valeria Calenda
Haematology
Ninox
Israel
Biography
Valérie Calenda began her career as research scientist in hematology and virology at theInstitut National de la Recherche Médicale (INSERM). After collaborating at a French/USresearch program on HIV at Davis University in California, she joined Transgene, an affiliateof Institut Mérieux focusing on immunotherapy, in 1994 where she was in charge of severalprojects focusing on HIV and Cardiovascular areas until 2000. She then led a spin-off project incardio-vascular therapeutic area before collaborating with a Paris based seed Venture Capitalfirm. Valérie also managed several biotech clinical-stage product developments within theinfectious diseases and oncology disease areas, from pre-IND to Phase 2. This led her to manage both in-licensing and out-licensing activities, including global license agreement and alliance management with Hoffman La Roche, acquisition of biotech assets in Europe and in the US. Valérie joined Merieux Développement as a Partner in January 2010.Valérie received her PhD in Pharmacology from the University of Marseille and . She holds a degree in Hematology and a B.Sc. in Biochemistry-Immunology from the University of Marseille.
Research Interest
Medical Devices